Compound Radar

Teladoc Health, Inc. (TDOC) Stock Analysis

Price $6.26
Market cap $1.14B
Next earnings Oct 28, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

31
31/100 Avoid
  • Financial Health 5
  • Profitability 25
  • Business Quality 75
  • Balance Sheet 25
  • Cash Flow 35

Why this rating?

Health 31/100 — Avoid

Strongest Business Quality 75/100
Softest Financial Health 5/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Teladoc Health, Inc. (TDOC) is a Health Information Services company in the Healthcare sector. Compound Radar rates Teladoc Health, Inc. 31/100 (Avoid) due to high business quality and elevated leverage.

Investment profile

  • Quality High
  • Growth Soft
  • Balance Sheet Stretched

Financial highlights

Valuation

  • Forward P/E -7.97
  • EV/Revenue 0.56

Profitability

  • Revenue Growth -4.0%
  • Gross Margin 69.0%
  • Operating Margin -5.7%
  • Net Margin -7.1%
  • ROE -13.0%

Financial strength

  • Cash $774.35M
  • Debt $1.04B
  • Net Cash $-261.86M
  • Free Cash Flow $137.33M
  • Current Ratio 0.83

Similar companies

Peers in Health Information Services, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Health Information Services →

FAQ

How Compound Radar scores and tracks Teladoc Health, Inc. (TDOC).

View Methodology & FAQ →